Microglial alterations have furthermore been demonstrated in different Tauopathies using postmortem analysis [5, 46, 64, 80, 99] and using in vivo PET analysis to strongly correlate with Tau pathology in Tauopathies including CBD, PSP and FTD [27, 28, 67]. The gene discussed is MAPT; the disease is frontotemporal dementia.